#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hodgkin's disease recurrent Paraneoplastic neurological syndrome Complex regional pain syndrome Paraganglion neoplasm Arteriovenous malformation Hepato-lenticular degeneration Brain stem glioma Mantle cell lymphoma refractory Hypoxic-ischaemic encephalopathy Leiomyosarcoma Leukodystrophy Haemolytic uraemic syndrome Fibrosarcoma Glomerulonephritis chronic Acquired C1 inhibitor deficiency More trials…

    Learn about Rare Diseases

    Arterial tortuosity syndrome Chronic granulomatous disease – Basic Information Chondrosarcoma – Diagnostics Glycogen storage disease type II – Treatment Osteosarcoma – Life with Disease Medulloblastoma recurrent – Diagnostics Breast angiosarcoma – Trials in Disease Pelizaeus-Merzbacher disease – Life with Disease KBG syndrome – Basic Information Alagille syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Guselkumab Alisertib Sodium Iodine (123I) Iobenguane Abc-15Bo-116 Crizanlizumab Nebivolol Soya Oil, Purified Doxazosin Mesilate Ipatasertib Naloxone Pyrazinamide Ict01 Rilzabrutinib Fluconazole Levobupivacaine Tofogliflozin SODIUM TETRACHLOROPALLADATE DIMENHYDRINATE Colesevelam Retinol Palmitate More therapies…

    Learn about Your Condition

    Circulatory collapse Immunodeficiency congenital Addison's disease Neuropathy peripheral Adenocarcinoma of colon Tricuspid valve disease Erosive oesophagitis Anal cancer recurrent Juvenile idiopathic arthritis Rectal cancer Hypertension Systemic infection K-ras gene mutation Acute cardiac event Infant sedation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Renal transplant

  • Study on Optimizing Immunosuppressive Treatment for Living Donor Kidney Transplant Patients Using Prednisone, Basiliximab, and Tacrolimus Monohydrate

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Basiliximab
    • Rabbit Anti-Human Thymocyte Immunoglobulin
    • Tacrolimus Monohydrate
    Spain

  • Study on the Safety and Effectiveness of Oral Semaglutide for Patients with High Blood Sugar After Kidney Transplantation

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Hyperglycaemia
    • Renal transplant
    Investigated Drugs:
    • Placebo
    • Semaglutide
    Denmark

  • Comparing tacrolimus and mycophenolate mofetil bioequivalence in kidney transplant recipients taking immunosuppressive medications

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Mycophenolate Mofetil
    • Tacrolimus
    Norway

  • Study on Immune System Suppression Using Donor Modified Immune Cells (MIC) for Patients Undergoing Living Donor Kidney Transplantation

    Not recruiting

    2 1 1
    Investigated Drugs:
    • ALLOGENEIC PERIPHERAL BLOOD MONONUCLEAR CELLS INCUBATED IN VITRO WITH MITOMYCIN C
    Germany

  • Study on How Pantoprazole Affects the Absorption of Mycophenolate Mofetil in Post-Transplant Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Heart transplant
    • Liver transplant
    • Renal transplant
    Investigated Drugs:
    • Pantoprazole
    • Mycophenolate Mofetil
    The Netherlands

  • Study on the Immediate Effects of Empagliflozin on Kidney Transplant Oxygen Levels in Kidney Transplant Recipients

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Empagliflozin
    Denmark
Previous Page
1 … 4 5 6 7 8 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!